Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Musculoskeletal | Family Medicine
 Disease Category: Chronic Pain
Location: United States, IL

Trial Information

A Multi-Center, Prospective, Randomized, Controlled, Single-Blind Evaluation of the Safety and Efficacy of Percutaneous Lumbar Epidural Adhesiolysis in the Treatment of Painful Spinal Stenosis

To evaluate the safety and efficacy of epidural adhesiolysis as compared to caudal steroid injections in the treatment of painful lumbar spinal stenosis.

Inclusion Criteria

  • Subject is over 18 years of age
  • Subjects with a history of chronic low back pain of at least six months in duration
  • Subject has radicular pain symptoms consistent with lumbar spinal stenosisa
  • Radiographic (MRI, myelogram or CT) evidence of spinal stenosisa at or below L3
  • Subject has been diagnosed with painful lumbar spinal stenosis

Exclusion Criteria

  • Large contained or sequestered herniation. A small-contained herniation is permitted (< 4mm)
  • Cauda Equina symptoms and/or compressive radiculopathy
  • Prior caudal epidural steroid injection
  • Pre-existing arachnoiditis
  • Previous discectomy or microdiscectomy
  • Vasogenic claudication

Jessica Lowe, Clinical Research Coordinator
Millennium Pain Center
1015 S Mercer Ave.
Bloomington, IL 61701
Phone: 309-662-4321
Fax: 309-661-4815
Email: jlowe@millenniumpaincenter.com

View Map

Research Center Information: Millennium Pain Center

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.